Thermo Fisher Scientific (TMO) Change in Receivables (2009 - 2020)

Thermo Fisher Scientific has reported Change in Receivables for 12 years, with the latest figure at $444.0 million in Q4 2020.

• Change in Receivables for Q4 2020 came in at $444.0 million, up 562.5% year-over-year; the trailing twelve-month figure through Dec 2020 was $1.3 billion (up 478.67% YoY), and the FY2025 annual result was $426.0 million, up 149.12% from the prior year.
• Change in Receivables eased to $444.0 million in Q4 2020, from $663.0 million in the prior quarter.
• Over five years, Change in Receivables peaked at $663.0 million in Q3 2020 and troughed at -$96.0 million in Q4 2019.
• A 5-year average of $130.4 million and a median of $49.6 million in 2016 frame the typical range for Change in Receivables.
• The widest annual swing landed in 2016, when Change in Receivables soared 7629.03%; it then sank 230.77% in 2019.
• A 5-year view of Change in Receivables shows it stood at $239.6 million in 2016, then declined by 16.11% to $201.0 million in 2017, then soared by 50.25% to $302.0 million in 2018, then slumped by 131.79% to -$96.0 million in 2019, then jumped by 562.5% to $444.0 million in 2020.
• Per Business Quant data, the three most recent Change in Receivables figures were $444.0 million in Q4 2020, $663.0 million in Q3 2020, and -$23.0 million in Q2 2020.